Monday, November 9
6:30  - 7:00 p.m. - Dinner and Presentation, followed by M&A Panel

Ernst & Young will release its second annual industry publication, Pulse of the industry: Global medical technology report 2009 this October. This seminal report classifies medtech companies by product and disease segments and represents a comprehensive measurement of the industry’s performance across several measures — financial performance, financing, mergers and acquisitions and public policy trends.

At the end of September 2008, when Ernst & Young released its inaugural report, the industry’s aggregate market capitalization, public equity financing, venture capital and deal activity were extremely healthy. To put it mildly, the world has changed a lot since then. Stocks have plummeted, governments have spent billions to shore up their economies, and the crisis has spread swiftly across industries and geographies. How has medtech held up during the global financial crisis?

Speaker: Scott Sarazen, Global Life Sciences Markets Leader, Ernst & Young

Scott serves in the role of Markets Leader within Ernst & Young’s Global Life Sciences Center.  In this role, Scott is responsible for all aspects of the firm's global marketing, communication and go-to-market strategies for the pharmaceutical, biotechnology and medtech industries.  Mr. Sarazen and the marketing team serve as the primary conduit between the firm and the life science industries for the purposes of tracking the changing landscape of these dynamic sectors and communicating E&Y’s proven value proposition. 

Mr. Sarazen has enjoyed over 20 years of experience working directly and indirectly in the life science industries.  Prior to joining EY in 2006, Scott’s career has included roles in biopharmaceutical facilities design, strategic operations and business development in positions as: Senior Vice President of Corporate Development at Straumann, North America and Director of Global Planning and Development at Genzyme Corporation.  Scott has also served in public economic development roles, advocating for the expansion of the biomedical industries, as the Senior Vice President for Life Sciences with MassDevelopment for the Commonwealth of Massachusetts and as a special consultant to the Chief Economic Development Officer for the City of Boston.

Mr. Sarazen holds a Bachelors of Science in Engineering from Worcester Polytechnic Institute and a Masters of Science in Management from Lesley University.

In addition to other affiliations, Scott serves on the: Advisory Board of the Harvard-MIT Division of Health Sciences and Technology (HST); Board of Trustees for the KIPP Academy in Lynn, MA; the Advisory Board for the City of Boston’s Life-Tech Initiative; Advisory Board for Boston World Partnerships; and on the Economic Development Committee at the Massachusetts Biotechnology Council.